For example, mutation/amplification of EGFR in lung cancer cell lines was associated with an increased dependency upon FES (p = 3 × 10−2; Figure 3F), previously identified as an EGFR binding partner (Jones et al., 2006). The gene discussed is FES; the disease is lung carcinoma.